Intensive glucose-lowering and the risk of vascular events and premature death in patients with decreased kidney function: The ADVANCE trial. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/dom.13878
PubMed Identifier: 31486188
Publication URI: http://europepmc.org/abstract/MED/31486188
Type: Journal Article/Review
Volume: 22
Parent Publication: Diabetes, obesity & metabolism
Issue: 3
ISSN: 1462-8902